Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.

S Wang1, N Nath, M Adlam

  • 1Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

Oncogene
|June 22, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The cardiovascular effects of positive pressure ventilation.

BJA education·2021
Same author

District-level epidemiology, hot spots and sociodemographic determinants of tobacco use in Indian men and women: analysis of national family health survey-4 (2015-16).

Public health·2021
Same author

Pre-operative nerve blocks for hip fracture - 2.

Anaesthesia·2013
Same author

Detection of filarial antibody using an fiber optics immunosensor (FOI).

Indian journal of clinical biochemistry : IJCB·2012
Same author

Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation.

Oncogene·2012
Same author

Birth of the first mithun ( Bos frontalis) calf through artificial insemination.

Animal : an international journal of animal bioscience·2012
Same journal

Aberrant splicing in human cancer shows possible functional impact on transcription factors.

Oncogene·2026
Same journal

The crosstalk between RNA m6A modification and protein lactylation: emerging insights into tumor progression.

Oncogene·2026
Same journal

Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.

Oncogene·2026
Same journal

Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C-mutant non-small cell lung cancer.

Oncogene·2026
Same journal

Histone lactylation-driven IGF2BP3 promotes intrahepatic cholangiocarcinoma progression via SPP1/CD44-dependent macrophage polarization.

Oncogene·2026
Same journal

Correction: SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle.

Oncogene·2026
See all related articles

Prohibitin, a novel protein, interacts with retinoblastoma (Rb) family proteins to suppress cell growth by inhibiting E2F transcription factors. This interaction is crucial for cell cycle regulation and shows potential as a tumor suppressor.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Retinoblastoma (Rb) tumor suppressor proteins regulate the cell cycle by inhibiting E2F transcription factors.
  • Disruption of the Rb-E2F interaction promotes cell proliferation.

Purpose of the Study:

  • To characterize the novel interaction between Rb family proteins and prohibitin.
  • To investigate prohibitin's role in regulating E2F activity and cell proliferation.

Main Methods:

  • In vitro and in vivo binding assays to confirm physical interaction between Rb proteins and prohibitin.
  • Reporter assays to assess prohibitin's effect on E2F-mediated transcription.
  • Analysis of prohibitin mutant lacking Rb-binding ability.

Main Results:

Related Experiment Videos

  • Prohibitin physically interacts with Rb, p107, and p130.
  • Prohibitin effectively represses E2F-mediated transcription for E2Fs 1-5.
  • Adenovirus E1A protein did not reverse prohibitin-mediated E2F repression.
  • A prohibitin mutant unable to bind Rb showed impaired repression of E2F activity and cell proliferation.

Conclusions:

  • Prohibitin is a novel regulator of E2F activity and cell cycle progression.
  • Prohibitin's interaction with Rb family proteins is essential for its tumor suppressive function.
  • Prohibitin may be a target for therapeutic intervention in cancer.